| 價(jià)格 | 詢價(jià) |
| 包裝 | 1支 |
| 最小起訂量 | 1支 |
| 發(fā)貨地 | 湖北 |
| 更新日期 | 2026-07-08 |
| 中文名稱:重組人NKp44 (C-6His)蛋白 | 英文名稱:Recombinant Human NKp44 (C-6His) |
| 品牌: EnkiLife | 產(chǎn)地: 中國(guó) |
| 保存條件: Store at ≤-70°C, stable for 6 months after receipt.Store at ≤-70°C, stable for 3 months under sterile conditions after opening. Please minimize freeze-thaw cycles. | 產(chǎn)品類別: 重組蛋白 |
| 是否進(jìn)口: 否 | 用途: 科研 |
| 產(chǎn)品名稱 |
Recombinant Human NKp44 (C-6His) |
| 英文名稱 |
NCR2/NKp44/CD336 |
| 純度 |
Greater than 95% as determined by reducing SDS-PAGE |
| 內(nèi)毒素 |
<1 EU/μg as determined by LAL test. |
| 蛋白構(gòu)建 |
Recombinant Human Natural cytotoxicity triggering receptor 2 is produced by our Mammalian expression system and the target gene encoding Gln22-Pro190 is expressed with a 6His tag at the C-terminus. |
| Accession |
O95944 |
| 表達(dá)宿主 |
Human Cells |
| 種屬 |
Human |
| 預(yù)測(cè)分子量 |
19.4 KDa |
| 制劑 |
Lyophilized from a 0.2 μm filtered solution of PBS, pH 7.4. |
| 運(yùn)輸方式 |
The product is shipped at ambient temperature.Upon receipt, store it immediately at the temperature listed below. |
| 穩(wěn)定性&儲(chǔ)存 |
Store at ≤-70°C, stable for 6 months after receipt.Store at ≤-70°C, stable for 3 months under sterile conditions after opening. Please minimize freeze-thaw cycles. |
| 復(fù)溶 |
Always centrifuge tubes before opening.Do not mix by vortex or pipetting.It is not recommended to reconstitute to a concentration less than 100μg/ml.Dissolve the lyophilized protein in distilled water.Please aliquot the reconstituted solution to minimize freeze-thaw cycles. |
| 分子別名 |
| CD336 Protein; dJ149M18.1 Protein; LY95 Protein; NK-p44 Protein; NKP44 Protein; RP1-149M18.2 Protein |
| 背景介紹 |
| Natural cytotoxicity triggering receptor 2 (NCR2), also known as Natural killer cell p44-related protein (NKp44), or CD336, is a member of the natural cytotoxicity receptor (NCR) family, which composed of one Ig-like extracellular domain, a transmembrane segment, and a cytoplasmic domain. It is a novel transmembrane glycoprotein belonging to the Immunoglobulin superfamily characterized by a single extracellular V-type domain. The cytoplasmic domain of NKp44 also contains a sequence that matches the immunoreceptor tyrosine-based inhibitory motif (ITIM) consensus. This Cytotoxicity-activating receptor may contribute to the increased efficiency of activated natural killer (NK) cells to mediate tumor cell lysis. NKp44 is selectively expressed by IL-2-activated NK cells and may contribute to the increased efficiency of activated NK cells to mediate tumor cell lysis. Tumor cell recognition of the mutated NKp44 proteins was significantly reduced and correlated with their lower recognition of heparin. |
注意事項(xiàng)
本司產(chǎn)品僅用于科研,不用于臨床診斷和治療
| 成立日期 | 2024-08-02 (2年) | 注冊(cè)資本 | 271萬人民幣 |
| 員工人數(shù) | 10-50人 | 年?duì)I業(yè)額 | ¥ 100萬-300萬 |
| 主營(yíng)行業(yè) | 生化試劑,抗體,細(xì)胞培養(yǎng),癌癥研究,細(xì)胞生物學(xué) | 經(jīng)營(yíng)模式 | 工廠,試劑,定制,服務(wù) |
| 產(chǎn)品名稱 | 價(jià)格 | 公司名稱 | 報(bào)價(jià)日期 | |
|---|---|---|---|---|
| 詢價(jià) |
VIP3年
|
北京百普賽斯生物科技股份有限公司
|
2026-06-30 | |
| ¥3200 |
VIP1年
|
上海研生實(shí)業(yè)有限公司
|
2026-07-24 | |
| ¥3200 |
VIP5年
|
上海博爾森生物科技有限公司
|
2026-07-24 |